Zinc Deficiency and Its Management in The Pediatric Population - A Literature Review and Proposed Etiologic Classification 2013 - JAAD
Zinc Deficiency and Its Management in The Pediatric Population - A Literature Review and Proposed Etiologic Classification 2013 - JAAD
Zinc Deficiency and Its Management in The Pediatric Population - A Literature Review and Proposed Etiologic Classification 2013 - JAAD
Zinc is a trace element essential to the gastrointestinal, immune, integumentary, reproductive, and central
nervous systems. Zinc deficiency is prevalent in many areas of the world and is a diagnostically challenging
condition. Cutaneous manifestations typically occur in moderate to severe zinc deficiency and present as
alopecia and dermatitis in the perioral, acral, and perineal regions. Zinc deficiency is a potentially fatal
disease process. The aim of this review is to focus on the cutaneous manifestations, diagnosis, and
treatment of zinc deficiency in children, and to propose an etiologic classification system. ( J Am Acad
Dermatol 2013;69:616-24.)
Key words: acrodermatitis enteropathica; micronutrients; pediatric; zinc absorption; zinc deficiency; zinc
metabolism.
From the Department of Dermatology, University of Toronto,a and M1-700, Toronto, Ontario M4N 3M5, Canada. E-mail: michael.
Departments of Pediatrics and Dermatology, University of [email protected].
British Columbia.b Published online May 20, 2013.
Funding sources: None. 0190-9622/$36.00
Conflicts of interest: None declared. Ó 2013 by the American Academy of Dermatology, Inc.
Reprints not available from the authors. http://dx.doi.org/10.1016/j.jaad.2013.04.028
Correspondence to: Michael D. Corbo, MD, Department of
Dermatology, University of Toronto, 2075 Bayview Ave, Suite
616
J AM ACAD DERMATOL Corbo and Lam 617
VOLUME 69, NUMBER 4
Table III. Clinical manifestations of zinc deficiency Table IV. Etiologic classification system for zinc
Organ system Complication
deficiency in pediatric population
Integumentary system Delayed wound healing and Zinc deficiency category Examples
decreased tensile strength Type I: inadequate Total parenteral nutrition
of scar tissue intake without zinc
Scalp dermatitis supplementation
Alopecia Low maternal serum zinc
Dry skin levels in breast-feeding
Poor nail growth mothers
Bullous pustular dermatitis Low breast milk levels
Stomatitis Pregnancy in teenagers
Paronychia Inadequate or low-calorie diet
Blepharitis Anorexia nervosa or bulimia
Cheilitis nervosa
Immune system Increased allergic sensitivity Type II: excessive loss Fluid losseseintestinal fistula,
Increased inflammatory activity intractable diarrhea
Recurrent infections as result Increased urinary
of cell-mediated immune eliminationeliver cirrhosis,
dysfunction infection, renal disease,
Possible increased risk of diabetes mellitus, diuretics,
pneumonia alcohol
Gastrointestinal system Diarrhea Othereblood loss caused by
Anorexia parasitic infection, burns,
Hypogeusia (reduced excessive sweating,
ability to taste) hemodialysis, hemolysis
Abdominal pain Type III: malabsorption Acrodermatitis enteropathica
Glossitis High intake of copper/iron
Endocrine system Growth retardation Celiac disease
Hypogonadism Crohn’s disease
Central nervous system Neurosensory changes Ulcerative colitis
Psychological impairment Cystic fibrosis
Intention tremor Liver dysfunction
Impaired concentration Pancreatic dysfunction
Nystagmus Short bowel syndrome
Depression Irritable bowel disease
Night blindness High ingestion of phytates
Anosmia Ethylenediaminetetraacetic
Dementia acid
Dysarthria Penicillamine
Genitourinary system Hypogonadism Diuretics
Musculoskeletal system Decreased lean body mass Valproate
Bone fractures Type IV: increased Pregnancy
Pregnant state Delayed fetal growth demand Breast-feeding mothers
Low birth weight Preterm infants
Preterm labor Type V: other Down syndrome
Reduced fetal cognition Congenital thymus defect
and motor function
Spontaneous abortion
suspicion remains high, a trial of zinc supplementation vacuolization in the cytoplasm of necrotic keratino-
can be conducted to assess clinical response.85 A cytes are commonly observed features.88
detailed dietary history, checking for other nutritional
deficiencies (ie, iron, vitamin D, and vitamin B12), and Differential diagnosis for zinc deficiency
analysis of maternal breast milk, if applicable, can also A number of disorders can present with signs and
be obtained.85 symptoms similar to zinc deficiency (Table V).
Histopathology TREATMENT
Histopathologic findings on light microscopy of Approximately 70% of patients with zinc defi-
skin biopsy specimens can be similar to those seen in ciency respond positively to zinc supplementation if
other deficiency states, such as vitamin B3 defi- initiated within 6 months of onset.58 The skin lesions
ciency.17 Confluent parakeratosis, a noticeably thin- heal without permanent sequelae, but extended
ner granular layer, focal spongiosis, and epidermal periods of deficiency may have permanent effects
acanthosis may be visualized in the early stages (Fig on growth and development in children.58,89 Studies
2). A collection of findings referred to as ‘‘necrolysis’’ of zinc deprivation on rats demonstrated reduced
can be appreciated in advanced disease. These motor activity, decreased brain mass, and short-term
include cytoplasmic pallor, ballooning and reticular memory loss persisting from early life to adult-
degeneration, and necrosis of keratinocytes in the hood.90 Similar experiments in mice showed stunted
stratum spinosum and granulosum.86 Nonspecific growth patterns, impaired learning and working
cytoplasmic pallor is the first of these findings to memory, and long-term immune dysfunction.91
appear and is often observed in isolation.17 Therapy is administered for up to 3 to 4 months in
Condensed chromatin in the nuclei of affected reversible deficiencies, but can be needed for more
keratinocytes and neutrophil crusts may be pre- than 6 months in patients showing only modest
sent.17 Chronic lesions typically exhibit psoriasiform gains.58 Children with acquired zinc deficiency should
hyperplasia with little to no cytoplasmic pallor.87 receive elemental zinc at 0.5 to 1 mg/kg/d to replenish
Under the electron microscope, swelling of the stores.49 Children with conditions leading to excessive
stratum spinosum, an intact basal lamina, and losses may require higher doses.49 Children with AE
622 Corbo and Lam J AM ACAD DERMATOL
OCTOBER 2013
should receive 3 mg/kg/d of elemental zinc for life or 10. Vallee BL, Falchuk KH. The biochemical basis of zinc physi-
have dosage guided by serum zinc measurements49; ology. Physiol Rev 1993;73:79-118.
11. Wuehler SE, Peerson JM, Brown KH. Use of national food
serum zinc measurements should be conducted every balance data to estimate the adequacy of zinc in national
3 to 6 months.17 Copper and iron levels should also be food supplies: methodology and regional estimates. Public
assessed regularly as a result of their interaction with Health Nutr 2005;8:812-9.
zinc. With adequate supplementation, symptoms be- 12. US Department of Agriculture, Agricultural Research Service.
gin to resolve after 1 or 2 days.49 For children with a USDA national nutrient database for standard reference, release
24. Nutrient data laboratory home page. Available from: URL:
dietary deficiency, a reduction in fiber, phytates, and http://www.ars.usda.gov/ba/bhnrc/ndl. Accessed March 4, 2012.
cadmium ingestion, if applicable, and introduction of 13. Prasad AS. Clinical spectrum of human zinc deficiency. In:
meat, liver, and other zinc-containing foods should Prasad AS, editor. Biochemistry of zinc. New York: Plenum
serve as adequate treatment.57,64 In most instances, Press; 1993. pp. 219-58.
treatment of the responsible underlying condition will 14. Leonard MB, Zemel BS, Kawchak DA, Ohene-Frempong K,
Stallings VA. Plasma zinc status, growth, and maturation in
result in resolution of symptoms. children with sickle cell disease. J Pediatr 1998;132:467-71.
Caution must be exercised so as not to exceed 15. Wang K, Zhou B, Kuo YM, Zemansky J, Gitschier J. A novel
toxic limits of zinc supplementation. Acute zinc member of a zinc transporter family is defective in acroder-
overdose may cause diarrhea, light-headedness, matitis enteropathica. Am J Hum Genet 2002;71:66-73.
gait disturbances, lethargy, vomiting, epigastric 16. Wang X, Zhou B. Dietary zinc absorption: a play of Zips and
ZnTs in the gut. IUBMB Life 2010;62:176-82.
pain, and abdominal cramps.58,92 Chronic overdose 17. Maverakis E, Fung MA, Lynch PJ, Draznin M, Michael DJ,
may lead to neutropenia, leukopenia, copper and/or Ruben B, et al. Acrodermatitis enteropathica and an overview
iron deficiency, anemia, growth retardation, de- of zinc metabolism. J Am Acad Dermatol 2007;56:116-24.
creased high-density lipoprotein, and increased 18. Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev
low-density lipoprotein.58,92 Nutr 2004;24:151-72.
19. Liuzzi JP, Bobo JA, Lichten LA, Samuelson DA, Cousins RJ.
Responsive transporter genes within the murine
intestinal-pancreatic axis form a basis of zinc homeostasis.
CONCLUSION Proc Natl Acad Sci U S A 2004;101:14355-60.
Zinc deficiency can be a diagnostically challeng- 20. Lind T, Lonnerdal B, Stenlund H, Ismail D, Seswandhana R,
ing condition. We believe our proposed etiologic Ekstr€om EC, et al. A community-based randomized controlled
trial of iron and zinc supplementation in Indonesian infants:
classification system may help facilitate the diagnosis
interactions between iron and zinc. Am J Clin Nutr 2003;77:
and management of zinc deficiency in children. 883-90.
21. Lonnerdal B. Dietary factors influencing zinc absorption.
A special thanks to Dr Isabel Colmenero, Dr Angela
J Nutr 2000;130:1378S.
Hernandez-Martın, and Dr Antonio Torrelo for their assis-
22. Shrimpton R, Shankar AH. Zinc deficiency. In: Semba RD,
tance with obtaining the clinical and histopathological Bloem MW, editors. Nutrition and health in developing
images. A special thanks to Dr Faisal Al-Mohammedi for countries. 2nd ed. Totowa (NJ): Humana Press (Springer
interpreting the findings in the histopathology images. Science and Media LLC); 2008.
23. King JC, Shames DM, Woodhouse LR. Zinc homeostasis in
REFERENCES humans. J Nutr 2000;130:S1360-6.
1. Tuerk MJ, Fazel N. Zinc deficiency. Curr Opin Gastroenterol 24. Ganapathy S, Volpe SL. Zinc, exercise, and thyroid hormone
2009;25:136-43. function. Crit Rev Food Sci Nutr 1999;39:369-90.
2. Sandstead HH. Understanding zinc: recent observations and 25. National Institutes of Health: Office of Dietary Supplements.
interpretations. J Lab Clin Med 1994;124:322-7. Dietary supplement fact sheet: zinc. Available from: URL:
3. Solomons NW. Mild human zinc deficiency produces an http://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/.
imbalance between cell-mediated and humoral immunity. Accessed February 20, 2012.
Nutr Rev 1998;56:27-8. 26. Panel on Micronutrients, Subcommittees on Upper Reference
4. Prasad AS. Zinc: an overview. J Nutr 1995;11:93-9. Levels of Nutrients and of Interpretation and Use of Dietary
5. Heyneman CA. Zinc deficiency and taste disorders. Ann Reference Intakes, Standing Committee on the Scientific
Pharmacother 1996;30:186-7. Evaluation of Dietary Reference Intakes. 12 Zinc. Dietary
6. Fabris N, Mocchegiani E. Zinc, human diseases and aging. reference intakes for vitamin A, vitamin K, arsenic, boron,
Aging (Milano) 1995;7:77-93. chromium, copper, iodine, iron, manganese, molybdenum,
7. Maret W, Sandstead HH. Zinc requirements and the risks and nickel, silicon, vanadium, and zinc. Washington (DC): National
benefits of zinc supplementation. J Trace Elem Med Biol Academies Press; 2001. p. 442-501.
2006;20:3-18. 27. Prasad AS, Beck FW, Snell DC, Kucuk O. Zinc in cancer
8. Prasad AS, Beck FW, Grabowski SM, Kaplan J, Mathog RH. prevention. Nutr Cancer 2009;61:879-87.
Zinc deficiency: changes in cytokine production and T-cell 28. Lachance PA, Nakat Z, Jeong W. Antioxidants: an integrative
subpopulations in patients with head and neck cancer and in approach. J Nutr 2001;17:835-8.
noncancer subjects. Proc Assoc Am Physician 1997;109:68-77. 29. Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N,
9. Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME. et al. Zinc inhibits nuclear factor-k B activation and sensitizes
Zinc and human health: an update. Arch Toxicol 2012;86: prostate cancer cells to cytotoxic agents. Clin Can Res 2002;8:
521-34. 3579-83.
J AM ACAD DERMATOL Corbo and Lam 623
VOLUME 69, NUMBER 4
30. Ho E, Quan N, Tsai YH, Lai W, Bray TM. Dietary zinc 51. Murthy SC, Udagani MM, Badakali AV, Yelameli BC. Sympto-
supplementation inhibits NF-kappa B activation and protects matic zinc deficiency in a full-term breast-fed infant. Derma-
against chemically induced diabetes in CD1 mice. Exp Biol tol Online J 2010;16:3.
Med 2001;226:103-11. 52. Gehrig KA, Dinulos JG. Acrodermatitis due to nutritional
31. Prasad AS, Bao B, Beck FWJ, Kucuk O, Sarkar FH. Anti-oxidant deficiency. Curr Opin Pediatr 2010;22:107-12.
effect of zinc in humans. Free Radic Biol Med 2004;37: 53. Chowanadisai W, Lonnerdal B, Kelleher SL. Identification of a
1182-90. mutation in SLC30A2 (ZnT-2) in women with low milk zinc
32. Davis JN, Kucuk O, Djuric Z, Sarkar FH. Soy isoflavone concentration that results in transient neonatal zinc defi-
supplementation in healthy men prevents NF-k B activation ciency. J Biol Chem 2006;281:39699-707.
by TNF-a in blood lymphocytes. Free Radic Biol Med 2001;30: 54. Seo YA, Kelleher SL. Functional analysis of two single
1293-302. nucleotide polymorphisms in SLC30A2 (ZnT2): implications
33. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and for mammary gland function and breast disease in women.
NF-kB signaling. Cell Res 2011;21:103-15. Physiol Genom 2010;42A:219-27.
34. Van Den Oord JJ, De Ley M. Distribution of metallothionein in 55. Krebs NF, Westcott JE, Butler N, Robinson C, Bell M,
normal and pathological human skin. Arch Dermatol Res Hambidge KM. Meat as a first complementary food for
1994;286:62-8. breastfed infants: feasibility and impact on zinc intake and
35. Schwartz JR, Marsh RG, Draelos ZD. Zinc and skin health: status. J Pediatr Gastroenterol Nutr 2006;42:207-14.
overview of physiology and pharmacology. Dermatol Surg 56. Hambidge KM, Krebs NF. Zinc deficiency: a special challenge.
2005;31:837-47. J Nutr 2007;137:1101-5.
36.
Agren MS. Zinc in wound repair. Arch Dermatol 1999;135: 57. Cole CR, Grant FK, Swaby-Ellis ED, Smith JL, Jacques A,
1273-4. Northrop-Clewes CA, et al. Zinc and iron deficiency and their
37.
Agren MS, Chvapil M, Franzen L. Enhancement of interrelations in low-income African American and Hispanic
re-epithelialization with topical zinc oxide in porcine children in Atlanta. Am J Clin Nutr 2010;91:1027-34.
partial-thickness wounds. J Surg Res 1991;50:101-5. 58. Yanagisawa H. Zinc deficiency and clinical practice. Japan
38. Jin L, Murakami TH, Janjua NA, Hori Y. The effects of zinc Medical Association Journal 2004;47:359-64.
oxide and diethyldithiocarbamate on the mitotic index of 59. Lukaski HC, Bolonchuk WW, Klevay LM, Milne DB, Sandstead
epidermal basal cells of mouse skin. Acta Med Okayama HH. Changes in plasma zinc content after exercise in men fed
1994;48:231-6. a low-zinc diet. Am J Physiol 1984;247:88-93.
39. Hansson A. Extracellular zinc ions induces mitogen-activated 60. Milne DB, Canfield WK, Gallagher SK, Hunt JR, Klevay LM.
protein kinase activity and protein tyrosine phosphorylation Ethanol metabolism in postmenopausal women fed a diet
in bombesin-sensitive Swiss 3T3 fibroblasts. Arch Biochem marginal in zinc. Am J Clin Nutr 1987;46:688-93.
Biophys 1996;328:233-8. 61. Baer MJ, King JC. Tissue zinc levels and zinc excretion during
40. Huang JS, Mukherjee JJ, Chung T, Crilly KS, Kiss Z. Extracel- experimental zinc depletion in young men. Am J Clin Nutr
lular calcium stimulates DNA synthesis in synergism with 1984;39:556-70.
zinc, insulin and insulin-like growth factor I in fibroblasts. Eur 62. Hess FM, King JC, Margen S. Zinc excretion in young women
J Biochem 1999;266:943-51. on low zinc intakes and oral contraceptive agents. J Nutr
41. Lansdown ABG, Sampson B, Rowe A. Sequential changes in 1977;107:1610-20.
trace metal, metallothionein and calmodulin concentrations 63. Milne DB, Canfield WK, Mahalko JR, Sandstead HH. Effect of
in healing skin wounds. J Anat 1999;195:375-86. dietary zinc on whole body surface loss of zinc: impact on
42.
Agren MS, Franzen L. Influence of zinc deficiency on breaking estimation of zinc retention by balance method. Am J Clin
strength of 3-week-old skin incisions in the rat. Acta Chir Nutr 1983;38:181-6.
Scand 1990;156:667-70. 64. Dufner-Beattie J, Wang F, Kuo Y-M, Gitschier J, Eide D,
43. Nagase H, Visse R, Murphy G. Structure and function of Andrews GK. The acrodermatitis enteropathica gene ZIP4
matrix metalloproteinases and TIMPs. Cardiovasc Res 2006; encodes a tissue-specific, zinc-regulated zinc transporter in
69:562-73. mice. J Biol Chem 2003;278:33474-81.
44. Barron L, Wynn TA. Fibrosis is regulated by Th2 and Th17 65. Champion RH, Burton JL, Ebling FJG. Textbook of dermatol-
responses and by dynamic interactions between fibroblasts ogy. 5th ed. London, UK: Blackwell Scientific Publications;
and macrophages. Am J Physiol Gastrointest Liver Physiol 1992. p. 2373.
2011;300:G723-8. 66. Arnaud J, Favier A. Determination of ultrafiltrable zinc in
45. Mirastschijski U, Impola U, Jahkola T, Karlsmark T, Agren MS, human milk by electrothermal atomic absorption spectrom-
Saarialho-Kere U. Ectopic localization of matrix metallo- etry. Analyst 1992;117:1593-8.
proteinase-9 in chronic cutaneous wounds. Hum Pathol 67. Weymouth RD, Kelly R, Lansdell BJ. Symptomatic zinc defi-
2002;33:355-64. ciency in a premature infant. Aust Paediatr J 1982;18:208-10.
46. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases 68. Garretts M, Molokhia M. Acrodermatitis enteropathica with-
and the regulation of tissue remodeling. Nat Rev Mol Cell Biol out hypozincemia. J Pediatr 1977;91:492-4.
2007;8:221-33. 69. Mack D, Koletzko B, Cunnane S, Cutz E, Griffiths A. Acroder-
47. Mirastschijski U, Zhou Z, Rollman O, Tryggvason K, Agren MS. matitis enteropathica with normal serum zinc levels: diag-
Wound healing in membrane-type-1 matrix metalloproteinase- nostic value of small bowel biopsy and essential fatty acid
deficient mice. J Invest Dermatol 2004;123:600-2. determination. Gut 1989;30:1426-9.
48. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regu- 70. Wester PO. Urinary zinc excretion during treatment with
lators of wound healing. Int J Biochem Cell Biol 2008;40:1334-47. different diuretics. Acta Med Scand 1980;208:209-12.
49. Jen M, Yan AC. Syndromes associated with nutritional 71. Keen CL, Taubeneck MW, Daston GP, Rogers JM, Gershwin
deficiency and excess. Clin Dermatol 2010;28:669-85. ME. Primary and secondary zinc deficiency as factors under-
50. Ackland ML, Michalczyk A. Zinc deficiency and its inherited lying abnormal CNS development. Ann. N Y Acad Sci 1993;
disordersea review. Genes Nutr 2006;1:41-50. 678:37-47.
624 Corbo and Lam J AM ACAD DERMATOL
OCTOBER 2013
72. Krebs NF. Zinc supplementation during lactation. Am J Clin 82. Liuzzi JP, Lichten LA, Rivera S, Blanchard RK, Aydemir TB,
Nutr 1998;68:S509-12. Knutson MD, et al. Interleukin-6 regulates the zinc trans-
73. Donangelo CM, Vargas-Zapata CL, Woodhouse LR, Shames porter Zip14 in liver and contributes to the hypozincemia of
DM, Mukherjea R, King JC. Zinc absorption and kinetics the acute-phase response. Proc Natl Acad Sci U S A 2005;102:
during pregnancy and lactation in Brazilian women. Am J 6843-8.
Clin Nutr 2005;82:118-24. 83. Pilch SM, Senti FR. Analysis of zinc data from the second
74. Bjorksten B, Back O, Gustavson KH, Hallmans G, H€aggl€ of B, national health and nutrition examination survey (NHANES
T€arnvik A. Zinc and immune function in Down’s syndrome. II). J Nutr 1985;115:1393-7.
Acta Paediatr Scand 1980;69:183-7. 84. Johnson PE, Hunt CD, Milne DB, Mullen LK. Homeostatic
75. Fabris N, Mocchegiani E, Muzzioli M, Provinciali M. Neuro- control of zinc metabolism in men: zinc excretion and
endocrine-thymus interactions: perspectives for intervention balance in men fed diets low in zinc. Am J Clin Nutr 1993;
in aging. Ann N Y Acad Sci 1988;521:72-87. 57:557-65.
76. Fabris N, Mocchegiani E, Muzzioli M, Provinciali M. The role of 85. Gibson RS, Hess SY, Hotz C, Brown KH. Indicators of zinc
zinc in neuroendocrine-immune interactions during aging. status at the population level: a review of the evidence. Br J
Ann N Y Acad Sci 1991;621:314-26. Nutr 2008;99:S14-23.
77. Franceschi C, Chiricolo M, Licastro F, Zannotti M, Masi M, 86. Mori H, Matsumoto Y, Tamada Y, Ohashi M. Apoptotic cell
Mocchegiani E, et al. Oral zinc supplementation in Down’s death in formation of vesicular skin lesions in patients
syndrome: restoration of thymic endocrine activity and of with acquired zinc deficiency. J Cutan Pathol 1996;23:
some immune defects. J Ment Defic Res 1988;32:169-81. 359-63.
78. Licastro F, Mocchegiani E, Masi M, Fabris N. Modulation of 87. Jensen SL, McCuaig C, Zembowicz A, Hurt MA. Bullous
the neuroendocrine system and immune functions by zinc lesions in acrodermatitis enteropathica delaying diagnosis
supplementation in children with Down’s syndrome. J Trace of zinc deficiency: a report of two cases and review of the
Elem Electrolytes Health Dis 1993;7:237-9. literature. J Cutan Pathol 2008;35:S1-13.
79. Licastro F, Chiricolo M, Mocchegiani E, Fabris N, Zannoti M, 88. Welsmann K, Kvist N, Kobayasi T. Bullous acrodermatitis due
Beltrandi E, et al. Oral zinc supplementation in Down’s to zinc deficiency during total parenteral nutrition: an ultra-
syndrome subjects decreased infections and normalized structural study of the epidermal changes. Acta Derm
some humoral and cellular immune parameters. J Intellect Venereol 1983;63:143-6.
Disabil Res 1994;38:149-62. 89. Kumar P, Lal NR, Mondal AK, Mondal A, Gharami RC, Maiti A.
80. Chiricolo M, Musa AR, Monti D, Zannotti M, Franceschi C. Zinc and skin: a brief summary. Dermatol Online J 2012;18:1.
Enhanced DNA repair in lymphocytes of Down syndrome 90. Frederickson C, Danscher G. Zinc-containing neurons in
patients: the influence of zinc nutritional supplementation. hippocampus and related CNS structures. Prog Brain Res
Mutat Res 1993;295:105-11. 1990;83:71-84.
81. Domell€ of M, Hernell O, Abrams SA, Chen Z, L€onnerdal B. Iron 91. Sandstead HH. Zinc: essentiality for brain development and
supplementation does not affect copper and zinc absorption function. Nutr Rev 1985;43:130-7.
in breastfed infants. Am J Clin Nutr 2009;89:185-90. 92. Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990;51:225-7.
J AM ACAD DERMATOL Corbo and Lam 624.e1
VOLUME 69, NUMBER 4